These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21167652)

  • 21. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensity-modulated radiotherapy followed by a brachytherapy boost for oropharyngeal cancer.
    Al-Mamgani A; Levendag PC; van Rooij P; Meeuwis CA; Sewnaik A; Teguh DN
    Head Neck; 2013 Dec; 35(12):1689-97. PubMed ID: 23483648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
    Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
    Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
    Tham IW; Lin S; Pan J; Han L; Lu JJ; Wee J
    Am J Clin Oncol; 2010 Jun; 33(3):294-9. PubMed ID: 20395788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Freedom from local and regional failure of contralateral neck with ipsilateral neck radiotherapy for node-positive tonsil cancer: results of a prospective management approach.
    Rusthoven KE; Raben D; Schneider C; Witt R; Sammons S; Raben A
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1365-70. PubMed ID: 19168295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical pathology of cancer of the oral cavity and oropharynx.
    Brennan CT; Sessions DG; Spitznagel EL; Harvey JE
    Laryngoscope; 1991 Nov; 101(11):1175-97. PubMed ID: 1943419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in oropharyngeal cancer--analysis of 627 cases receiving definitive radiotherapy.
    Agarwal JP; Mallick I; Bhutani R; Ghosh-Laskar S; Gupta T; Budrukkar A; Murthy V; Sengar M; Dinshaw KA
    Acta Oncol; 2009; 48(7):1026-33. PubMed ID: 19363712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Qin J; Wollner N
    Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.
    Chan AK; Huang SH; Le LW; Yu E; Dawson LA; Kim JJ; Cho BC; Bayley AJ; Ringash J; Goldstein D; Chan K; Waldron J; O'Sullivan B; Cummings B; Hope AJ
    Oral Oncol; 2013 Mar; 49(3):255-60. PubMed ID: 23079695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
    Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?
    Bedi M; Firat S; Semenenko VA; Schultz C; Tripp P; Byhardt R; Wang D
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e87-92. PubMed ID: 22516389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation therapy for early-stage carcinoma of the oropharynx.
    Selek U; Garden AS; Morrison WH; El-Naggar AK; Rosenthal DI; Ang KK
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):743-51. PubMed ID: 15183477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI
    Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined surgery and postoperative radiotherapy for oropharyngeal squamous cell carcinoma in Korea: analysis of 110 cases.
    Lim YC; Hong HJ; Baek SJ; Park JH; Kim GE; Lee CG; Lew DH; Lee WJ; Choi EC
    Int J Oral Maxillofac Surg; 2008 Dec; 37(12):1099-105. PubMed ID: 18722091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.
    Huang K; Xia P; Chuang C; Weinberg V; Glastonbury CM; Eisele DW; Lee NY; Yom SS; Phillips TL; Quivey JM
    Cancer; 2008 Aug; 113(3):497-507. PubMed ID: 18521908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma.
    Daly ME; Lieskovsky Y; Pawlicki T; Yau J; Pinto H; Kaplan M; Fee WE; Koong A; Goffinet DR; Xing L; Le QT
    Head Neck; 2007 Mar; 29(3):211-20. PubMed ID: 17111429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.